Candidiasis represents now the fourth most frequent nosocomial infection in the US and worldwide and C. albicans remains the most frequent causative agent of candidiasis. Unfortunately these infections are associated with unacceptably high morbidity and mortality rates. A variety of manifestations of candidiasis are associated with biofilm formation on the surface of different types of surfaces. Biofilm formation carries important consequences since sessile cells in biofilms display phenotypic traits that are dramatically different from their planktonic counterparts, such as increased resistance to antifungal agents and protection from host defenses. Once established, biofilms have the potential to initiate or prolong infections by providing a safe reservoir from which organisms can invade local tissue, seed new infection sites, or resist eradication efforts. The net effect is that Candida biofilms adversely impact the health of these patients, with increasing frequency and severity, and with soaring economic sequelae. Therefore, the main objective of the proposed studies is to devise novel strategies to prevent C. albicans biofilm formation. To this end we will: i) use a phenotype-based approach based on the high throughput screening for small molecule compounds which inhibit C. albicans biofilm formation, and ii) characterize the biofilm-inhibitory effects of selected bioactive molecules identified as """"""""hits"""""""" and """"""""leads"""""""" during the initial screens. These assays take advantage of a simple, rapid, robust, accurate and highly reproducible microtiter-based model for the formation of Candida biofilms developed in this laboratory that is ideally suited for automation and high throughput applications. Small-molecule-based approaches provide powerful means to address experimentally challenging and complex biological phenomena, such as biofilm formation, while simultaneously identifying new potential targets for drug development. to public health: Biofilm formation has severe consequences for human health. The main idea behind this study is that by eliminating the ability of C. albicans to form biofilms, a substantial reduction in morbidity, mortality and extended hospital stay can be achieved while simultaneously reducing healthcare costs. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DE017294-01A2
Application #
7317823
Study Section
Oral, Dental and Craniofacial Sciences Study Section (ODCS)
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
2007-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$205,883
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
800189185
City
San Antonio
State
TX
Country
United States
Zip Code
78249
Romo, Jesus A; Pierce, Christopher G; Chaturvedi, Ashok K et al. (2017) Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. MBio 8:
Pierce, Christopher G; Chaturvedi, Ashok K; Lazzell, Anna L et al. (2015) A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance. NPJ Biofilms Microbiomes 1:
Pierce, Christopher G; Saville, Stephen P; Lopez-Ribot, Jose L (2014) High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation. Pathog Dis 70:423-31
Martins, Margarida; Henriques, Mariana; Lopez-Ribot, José L et al. (2012) Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses 55:80-5
Srinivasan, Anand; Lopez-Ribot, Jose L; Ramasubramanian, Anand K (2012) Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening. J Vis Exp :e3845
Srinivasan, Anand; Uppuluri, Priya; Lopez-Ribot, Jose et al. (2011) Development of a high-throughput Candida albicans biofilm chip. PLoS One 6:e19036
Pierce, Christopher G; Uppuluri, Priya; Tummala, Sushma et al. (2010) A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp :
Uppuluri, Priya; Lopez-Ribot, Jose L (2010) An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence 1:483-7
Martins, Margarida; Uppuluri, Priya; Thomas, Derek P et al. (2010) Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 169:323-31
Uppuluri, Priya; Pierce, Christopher G; López-Ribot, José Luis (2009) Candida albicans biofilm formation and its clinical consequences. Future Microbiol 4:1235-7

Showing the most recent 10 out of 14 publications